A quantitative pharmacology model for cannabinoid CB1 receptor mediated by Gi/Gs protein competition

被引:0
|
作者
Yang, Liang [1 ]
Finlay, David B. [2 ]
Green, Hayley M. [2 ]
Zhu, Xiao [3 ]
Glass, Michelle [2 ]
Duffull, Stephen [1 ,4 ]
机构
[1] Univ Otago, Sch Pharm, Otago Pharmacometr Grp, POB 56, Dunedin, New Zealand
[2] Univ Otago, Dept Pharmacol & Toxicol, Dunedin, New Zealand
[3] Fudan Univ, Sch Pharm, Dept Clin Pharm & Pharm Adm, Shanghai, Peoples R China
[4] Certara, Princeton, NJ USA
关键词
CB1; receptor; cyclic AMP; G protein; mathematical model; CONCURRENT STIMULATION; AGONIST; ACTIVATION; EXPRESSION; MECHANISM; G(I/O); G(S);
D O I
10.1111/bph.16293
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and Purpose: Orthosteric agonism of the CB1 receptor normally associates with Gi signalling resulting in a net inhibition of cAMP production. Empirical evidence shows CB1 causes a net cAMP stimulation through Gs coupling under two conditions: co-stimulation with the D-2 receptor and high-level CB1 expression. Two hypotheses have been proposed to account for these paradoxical effects, (1) Gi is consumed by coupling to D-2 or extra CB1 and excess CB1 binds to Gs and (2), the formation of dimers CB1-CB1 or CB1-D-2 switches Gi/Gs preference. This study explored the mechanisms of Gi/Gs preference based on a mathematical model of the CB1 receptor.Experimental Approach: The model was based on Hypothesis 1 and known mechanisms. The model was calibrated to align with multiple types of data (cAMP, Gi dissociation and internalisation). The key step of Hypothesis 1 was examined by simulation from the model. An experiment was proposed to distinguish Hypothesis 1 and 2.Key Results: The model successfully descripted multiple types of data under Hypothesis 1. Simulations from the model indicated that precoupling of G protein with receptors is necessary for this hypothesis. The model designed experiments to distinguish Hypothesis 1 and 2 by increasing Gi & Gs in parallel with CB1 overexpression. The two hypotheses result in distinct cAMP responses.Conclusion and Implications: A mathematical model of CB1-regulated Gi/Gs pathways was developed. It indicated Hypothesis 1 is feasible and G protein precoupling is a key step causing cAMP signalling switch. The model-designed experiments provided guides for future experimentation.
引用
收藏
页码:1324 / 1340
页数:17
相关论文
共 50 条
  • [1] Cannabinoid 1 (CB1) Receptor - Pharmacology, Role in Pain and Recent Developments in Emerging CB1 Agonists
    Talwar, Rashmi
    Potluri, Vijay Kumar
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2011, 10 (05) : 536 - 544
  • [2] A kinetic model for positive allosteric modulator (PAM)-antagonists for the type 1 cannabinoid (CB1) receptor
    Yang, Liang
    Zhu, Xiao
    Finlay, David B.
    Green, Hayley
    Glass, Michelle
    Duffull, Stephen B.
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 (20) : 2661 - 2676
  • [3] The Cannabinoid CB1 Receptor in Schizophrenia
    Borgan, Faith
    Kokkinou, Michelle
    Howes, Oliver
    BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING, 2021, 6 (06) : 646 - 659
  • [4] Involvement of the carboxyl terminus of the third intracellular loop of the cannabinoid CB1 receptor in constitutive activation of Gs
    Abadji, V
    Lucas-Lenard, JM
    Chin, CN
    Kendall, DA
    JOURNAL OF NEUROCHEMISTRY, 1999, 72 (05) : 2032 - 2038
  • [5] Cannabinoid Receptor-Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation
    Smith, Tricia H.
    Blume, Lawrence C.
    Straiker, Alex
    Cox, Jordan O.
    David, Bethany G.
    Mcvoy, Julie R. Secor
    Sayers, Katherine W.
    Poklis, Justin L.
    Abdullah, Rehab A.
    Egertova, Michaela
    Chen, Ching-Kang
    Mackie, Ken
    Elphick, Maurice R.
    Howlett, Allyn C.
    Selley, Dana E.
    MOLECULAR PHARMACOLOGY, 2015, 87 (04) : 747 - 765
  • [6] Voltage dependence of the cannabinoid CB1 receptor
    Goldberger, Esty
    Tauber, Merav
    Ben-Chaim, Yair
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] Attenuation of morphine antinociceptive tolerance by cannabinoid CB1 and CB2 receptor antagonists
    Altun, Ahmet
    Yildirim, Kemal
    Ozdemir, Ercan
    Bagcivan, Ihsan
    Gursoy, Sinan
    Durmus, Nedim
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2015, 65 (05) : 407 - 415
  • [8] Structure of an allosteric modulator bound to the CB1 cannabinoid receptor
    Shao, Zhenhua
    Yan, Wei
    Chapman, Karen
    Ramesh, Karthik
    Ferrell, Aaron J.
    Yin, Jie
    Wang, Xuehui
    Xu, Qingping
    Rosenbaum, Daniel M.
    NATURE CHEMICAL BIOLOGY, 2019, 15 (12) : 1199 - +
  • [9] Cannabinoid CB1 Receptor Calibrates Excitatory Synaptic Balance in the Mouse Hippocampus
    Monory, Krisztina
    Polack, Martin
    Remus, Anita
    Lutz, Beat
    Korte, Martin
    JOURNAL OF NEUROSCIENCE, 2015, 35 (09) : 3842 - 3850
  • [10] Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor
    Calandra, B
    Portier, M
    Kernéis, A
    Delpech, M
    Carillon, C
    Le Fur, G
    Ferrara, P
    Shire, D
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 374 (03) : 445 - 455